profile picture of Akram Esfandani

Akram Esfandani

Graduate Student
Dulin Lab

Email: aesfandani@tamu.edu

Education

  • M.D. Isfahan University of Medical Sciences – Isfahan, Iran
  • Ph.D. Biology, Texas A&M University, in progress
  • Medicine
  • Neurology
  • Neuroscience
  • Spinal Cord Injury

Publications:

Harandi AA, Pakdaman H, Medghalchi A, Kimia N, Kazemian A, Siavoshi F, Barough SS, Esfandani A, Hosseini MH, Sobhanian SA. A randomized open-label clinical trial on the effect of Amantadine on post Covid 19 fatigue. Scientific Reports. 2024 Jan,14(1), 1343.

Harandi AA, Pakdaman H, Gharagozli K, Karamiani F, Goushki MS, Moini S, Sobhanian A, Maghsoudlu F, Esfandani A, Hosseini MH. MLC901 in Hypoxic-ischemic brain injury patients; A double-blind, randomized placebo-controlled trial. Medicine. 2023 Jun, 102(23): e33914; DOI:1097/MD.0000000000033914.

Harandi AA, Kimia N, Medghalchi A, Sharifipour E, Pakdaman H, Siavoshi F, Barough SS, Esfandani A, Hosseini MH. Cerebral hemodynamic response to generalized anxiety disorder. Psychiatry Research: Neuroimaging. 2023 Aug, 333:111654; DOI: 1016/j.pscychresns.2023.111654

Pakdaman H, Harandi AA, Gharagozli K, Siavoshi F, Barough SS, Sharifipour E, Esfandani A, Ilkhani S, Tabatabaei F, Sobhanian SA. A long-term study of NeuroAid (MLC601, MLC901) in patients with Alzheimer’s disease; an extension 8-year follow-up study. Current Aging Science. 2023 Mar; DOI:2174/1874609816666230224111759